about
T-Cell Abnormalities in Common Variable ImmunodeficiencyThe Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's DiseaseEpidemiology and pathophysiology of malignancy in common variable immunodeficiency?Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management.Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management.Autoimmunity in primary T-cell immunodeficiencies.IL-22 Produced by T helper Cell 22 as a New player in the Pathogenesis of Immune Thrombocytopenia.Soy protein and genistein improves renal antioxidant status in experimental nephrotic syndrome.Hydroxycitric acid ameliorates inflammation and oxidative stress in mouse models of multiple sclerosis.The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis.The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.The potential role of angiogenic factors in rheumatoid arthritis.The potential role of iNKT cells in experimental allergic encephalitis and multiple sclerosis.T-helper 22 cells as a new player in chronic inflammatory skin disorders.Clinical phenotype classification for selective immunoglobulin A deficiency.Characteristics of innate lymphoid cells (ILCs) and their role in immunological disorders (an update).Managing patients with side effects and adverse events to immunoglobulin therapy.The role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency.Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency.Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: A longitudinal study.Therapeutic effects of dasatinib in mouse model of multiple sclerosis.Cellular and molecular mechanisms of immune dysregulation and autoimmunity.Anti-aging effects of M2000 (β-D-mannuronic acid) as a novel immunosuppressive drug on the enzymatic and non-enzymatic oxidative stress parameters in an experimental model.Novel Mutation of ZAP-70-related Combined Immunodeficiency: First Case from the National Iranian Registry and Review of the Literature.Approach to the Management of Autoimmunity in Primary Immunodeficiency.Autoimmunity in Primary Antibody Deficiencies.Abnormality of regulatory T cells in common variable immunodeficiency.Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets.A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency.Cernunnos deficiency associated with BCG adenitis and autoimmunity: First case from the national Iranian registry and review of the literature.Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders.Anti-aging property of G2013 molecule as a novel immunosuppressive agent on enzymatic and non-enzymatic oxidative stress determinants in Rat model.Autoimmunity and its association with regulatory T cells and B cell subsets in patients with common variable immunodeficiency.Comparison of Bone Mineral Density in Common variable immunodeficiency and X-Linked Agammaglobulinaemia Patients.Measurement of Health-Related Quality of Life in Primary Antibody-Deficient Patients.The clinical significance of complete class switching defect in Ataxia telangiectasia patients.Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency.Evaluation of Tolerance in Patients With Type-1 Hypersensitivity Reaction to Wheat After Oral Immunotherapy.Calcium intervention ameliorates experimental model of multiple sclerosis.Primary ciliary dyskinesia in six patients with bronchiectasis.
P50
Q26745459-C20E9F05-94EC-4AC5-8143-CD07687CC331Q26781815-8174F34E-B815-4AC0-8F81-CEA38A78AA9FQ30234781-25ADFAFD-DF5C-4256-817E-8084C0FE2D56Q30244309-CB2AAD57-0CE9-4C1A-B8C0-CFA47B663B43Q30245322-56F202B5-57F1-4DAF-B7FE-D19E95710877Q30251616-E6474221-3DB9-42EF-A037-82B849755807Q33421582-8A09031B-926F-4AD7-BA8C-54808A492ED9Q35208725-361A6844-37D6-43C6-AC5F-63CA5FE4AF21Q37425219-47B3002B-12B6-4275-B1F0-F87D88AA853EQ38042681-7C657FA3-57F7-4C05-A3C4-74561E47FA34Q38177234-F5DE689E-3DD8-4B57-8230-752ED3DD862DQ38182175-CBEB2581-0CDD-4A76-B70B-ED1CC7A9F81DQ38193865-21CBEFA2-496C-449F-9994-33D7FD401128Q38548745-289050CC-F042-4AF2-BA1C-A1619D096538Q38573627-198EF11F-FE94-49C2-8A81-28F5D4878D65Q38597552-893BA8B1-7857-4D81-8B16-2C788894A0FAQ38614953-44377C10-698B-4963-B8B2-229121F3DECBQ38665495-BC9E2856-62CE-4C9F-84E9-A59D7B5BE95CQ38706233-0F3D6FFE-D4FE-4C0F-9053-AC44F47AEA63Q38781592-C8263A43-9AFC-46E7-B8F8-115772A13DEBQ38874789-57883C31-CF52-47FD-8625-D2EC381DC0E1Q38951070-1C106D83-4C15-4E0D-92BC-3CE909DA21B7Q38957648-0DF8F95E-BE0D-48F0-9D8F-C96FCF529384Q38985248-3D2FF359-D18D-4ACD-BC27-D0631D705E9DQ39012945-878E3079-866A-452C-A31C-F99F07CC6E1CQ39053214-DCF3FAE0-883D-487B-BFDE-55417D2F3773Q39174150-795FED98-25EC-4307-861F-70004D58C16DQ39310929-C5A8FD60-3126-458B-B3AD-4164BCC83000Q39391962-64586943-2EFD-4966-BCD5-39B773A0CAAEQ39448838-8F57C338-68A5-4B0F-8C1B-B927622207C4Q39450362-87FD0F89-EFE5-4FD4-8B92-8DE55E5DA4A4Q39975442-5E40372C-9E95-4BB1-9A2C-63E11D0CC7B3Q40111715-1A3DFE17-401B-4020-86D6-CFE9D33D14CAQ40163079-E0466C7B-B5E8-4D46-AF8F-0C3EC59D9DC8Q40272358-EBBC132C-4594-43A0-8AD4-5266935BCC0CQ40344962-4C1FF97F-DFF7-4B44-8CF8-7A0D0B526F67Q40528656-396D10D8-5E58-4113-8B97-3B8BA1AD66C9Q40529461-F49D1B87-E3F8-4490-B791-001CD326B3F8Q40542150-F4DF700D-3423-4C3C-A33A-99ACF0A345CFQ40654519-2ABD74DE-8F07-4C65-9EC6-44A5D86A96ED
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gholamreza Azizi
@ast
Gholamreza Azizi
@en
Gholamreza Azizi
@es
Gholamreza Azizi
@sl
type
label
Gholamreza Azizi
@ast
Gholamreza Azizi
@en
Gholamreza Azizi
@es
Gholamreza Azizi
@sl
prefLabel
Gholamreza Azizi
@ast
Gholamreza Azizi
@en
Gholamreza Azizi
@es
Gholamreza Azizi
@sl
P1053
B-9477-2018
P106
P1153
55440385100
P31
P3829
P496
0000-0001-5658-2511